B3-MED developed PharmFrame Intensive screening system for intensive care units

PharmFrame Intensive is a drug prescription screening system that assesses possible health risks for patients, among which are:

• Interactions between multiple prescribed medications.
• Allergic reactions to medications.
• Repeated prescribing of a medication due to polypragmasy.
• The age of the patient.
• Gender of the patient.
• Co-morbidities.
• Administration of drugs with unproven efficacy.
• Exceeding the maximum dosage of the drug.
• Exceeding the recommended duration of the drug course and other risks.

PharmFrame Intensive is adapted to the specifics of intensive care units: the system takes into account the specifics of patients, their diseases, and the medications prescribed to them.

PharmFrame Intensive has become a partner of the company developing a specialised add-on to medical information systems, which is used by leading intensive care units across Russia. In the near future, joint efforts are planned to expand the basic functionality by creating specialised calculators, analytical tools and other useful services for medical workers.

With PharmFrame Intensive medical organisations will be able to reduce risks for patients, facilitate the work of doctors and nursing staff, and improve the quality of medical care.